Abstract:Objective:To investigate the changes of lung function and inflammatory markers in children with asthma after standardized treatment.Methods:A retrospective study was performed on the clinical data of 198 children with asthma who were followed up for more than 3 years from January 2010 to October 2018, including 112 males and 86 females.The age was(8.92±3.41)years old, ranging from 4 to 14 years old.Children were divided into control group and difficult control group according to the level of disease control.According to whether or not the co-rhinitis was divided into asthma group and asthma with rhinitis group.According to the age of the first onset of children, divided into onset(first wheezing attack)≤3 years old group and onset > 3 years old group.Comparing inflammatory markers[immunoglobulin E(IgE), exhaled nitric oxide(FeNO)]and lung function levels[forced vital capacity in percent predicted values(FVC%pred), the forced expiratory volume in the first second in percent predicted values(FEV 1%pred), forced expiratory volume one second/forced vital capacity in percent predicted values(FEV 1/FVC%pred), peak expiratory flow in percent predicted values(PEF%pred), forced expired flow at 50% of forced vital capacity in percent predicted values(FEF50%pred), forced expired flow at 75% of forced vital capacity in percent predicted values(FEF75%pred)]. Results:After three years of standardized treatment, 154 patients were in control and 44 patients were in poor control.There were 42 asthmatic patients and 156 asthmatic patients with rhinitis.There were 138 cases with onset less than 3 years old, 60 cases more than 3 years old.The FEV 1/FVC%pred of the children in the refractory group was lower than that of the control group( P<0.05). In the third year of standardized treatment, the differences of FVC%pred, FEV 1%pred, FEV 1/FVC%pred, PEF% pred, FEF50% pred and FEF75%pred between the two groups were statistically significant( P<0.05). Before the beginning of treatment and three years of standardized treatment, there were no statistically significant differences in lung function indicators between the asthmatic group with rhinitis and the asthmatic group with asthma alone( P>0.05). At the beginning of treatment and the second year of standardized treatment, FVC%pred in the more than 3-year-old group was significantly lower than that in the group with onset ≤3 years old( P<0.05). In the first year of standardized treatment, FEV 1%pred, FEF50%pred and FEF75%pred were all higher than the group with onset ≤3 years old at the first year of standardized treatment( P<0.05). FeNO in more than 3-year group at the beginning of treatment and the third year of standardized treatment was higher than that in the group with onset less than 3 years old( P<0.05). Before treatment, IgE level in the control group[(185.00±251.43)IU/L]was significantly lower than that in the refractory group[(482.11±403.90)IU/L], ( P<0.001). After one year of standardized treatment, IgE levels[(275.40±281.36)IU/L]in the control group and[(224.48±252.04)IU/L]in the refractory group showed no statistically significant difference( P=0.596). Correlation analysis between FeNO and FEV 1%pred: FeNO was negatively correlated with FEV 1%pred in the first year of treatment initiation and standardized treatment( P<0.05). There was no correlation between the two at 2 and 3 years of follow-up. Conclusion:Early intervention and standardized management of allergic rhinitis and asthma are of great significance to improve the prognosis of children with asthma.

Application of Asthma Predictive Index-Based Group Therapy in Wheezing Children under 5 Years of Age

Clinical Observation of Montelukast Prevention for Wheezing Infants and Young Children after Brochiolitis

Retrospective analysis of impact of asthma predictive index on therapeutic effect and pulmonary function in children with asthma

Efficacy of Treatment with Montelukast, Fluticasone Propionate and Budesonide Liquid Suspension for the Prevention of Recurrent Asthma Paroxysms in Children with Wheezing Disorders

Efficacy of three different budesonide treatments in Chinese preschool children with recurrent wheezing

Short-term Effect of a Smart Nebulizing Device on Adherence to Inhaled Corticosteroid Therapy in Asthma Predictive Index-positive Wheezing Children

Treatment efficacy evaluation of standardized management for children with asthma

Treatment of Pediatric Mild Persistent Asthma with Low-Dose Budesonide Inhalation Suspension Vs.montelukast in China

Effectiveness of sublingual immunotherapy with house dust mite drops in asthmatic children at different ages

Associations Between ICS-based Maintenance Treatment and Asthma Outcome (asthma Control, Asthma Exacerbation Hospitalization and Emergency Department Visit) in Real World: Data from CARN Study

Clinical significance of asthma predictive index, Etoaxin, interleukin-4,interferon-γ in infants with recurrent wheezing

Benefit Effect of Sublingual Dust Mite Drops on the Control of Asthma in Children

Effectiveness of Drug Treatment Strategies to Prevent Asthma Exacerbations and Increase Symptom-Free Days in Asthmatic Children: A Network Meta-Analysis

Effectiveness of long term therapy of inhaled Steroids in Childhood Asthma: A Systemic Review

A Study on a Therapeutic Protocol to Improve the Control of Persistent Asthma by Monitoring Sputum Eosinophil Counts

Effect of corticosteroid inhalation and acupoint sticking on immune function in asthmatic children

ICS/LABA Combined With Subcutaneous Immunotherapy Modulates the Th17/Treg Imbalance in Asthmatic Children

A Clinical Study on the Significance of Airway Hyperresponsiveness Monitoring in the Adjustment of Combined Therapy for Asthmatic Patients

Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors.

A Study on Efficacy and Safety of Combine-Counter Gradient Therapy for Infants Wheezing

A follow-up study of children with asthma treated with standardized therapy